Pharmaceutical Primary Packaging Label Market Insight 2030
The global pharmaceutical primary packaging label market size was valued at $2,377.83 million in 2020, and is projected to reach $4,762.81 million by 2030 registering a CAGR of 7.20% from 2021 to 2030. The term "pharmaceutical primary packaging label" refers to all the printed information found on primary packaging of any over-the-counter medicine or prescription drug. Pharmaceutical product labelling is a highly regulated process that plays an important role in driving product approvals as well as maintaining data quality and safety. Each labelling leaflet contains important product information such as brand/drug name, manufacturer name and address, batch/lot number, product description details, active & inactive ingredients, indications, safety information, usage instructions, storage conditions, and expiration date.
Increase in number of counterfeiting cases and growth in demand for track and trace labels to protect patients from counterfeit medication , are main factors which drive the growth of the pharmaceutical primary packaging label market. In addition, due to concerns about climate change and other environmental issues, there has been an increase in the production of recyclable and biodegradable label products, which further fuel growth of the market.
What is the Impact of COVID-19 Pandemic on the Pharmaceutical Primary Packaging Label Market?
Rise in adoption of expanded content label design and growth in demand for cryogenic labels during COVID-19, as vaccines must be stored or transported in incredibly cold temperatures to maintain proper quality, are projected to further boost the growth of the market. However, stringent government regulations and standards expected to hinder growth of the market during the forecast period. On the other hand, growth in use of the smart labelling for patient engagement and identification are expected to offer profitable opportunities for growth of the market during the forecast period.
The outbreak of COVID-19 has disrupted workflows in the health care sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The global pharmaceutical primary packaging label market also declined in 2020, owing to global economic recession led by COVID-19. In addition, the COVID-19 outbreak disrupted the supply chain across various end-user industries such as foods & beverages, healthcare, and industrial. However, the market is expected to witness recovery in the year 2021, owing to increase in demand for pharmaceutical products such as antibiotics & antiviral drugs and COVID-19 vaccines, which also increases demand for pharmaceutical primary packaging labels.
For instance, in August 2020, Weiler Labeling Systems (WLS), part of ProMach Pharma Solutions, introduced their VR-72 labeler for COVID-19 vaccine packaging applications. Fully servo-driven with a modular design, this continuous motion pressure-sensitive system applies wrap-around labels to vials and other cylindrical products at speeds in excess of 600 vials per minute. In addition, increase in demand for cryogenic labels during COVID-19 for distribution of vaccines, which has positively impacted the pharmaceutical primary packaging label market.
Pharmaceutical Primary Packaging Label Market Segmentation
The global pharmaceutical primary packaging label market is segmented on the basis of primary packaging containers, face material, adhesive technology type, storage type, and region to provide a detailed assessment of the market. By primary packaging containers, the market is divided into prescription primary containers and OTC primary containers. The prescription primary containers segment is further divided into syringe, ampoules, vials, infusion bottles, and others. By face material, it is segmented into paper and film.
The film segment is further divided into polyethylene, polypropylene, and others. By adhesive technology type, it is segmented into solvent acrylic, hotmelt rubber, water base emulsion acrylic, and UV curable. By storage type, it is divided into cryogenic & refrigerated storage products and non-refrigerated storage products. The cryogenic and refrigerated storage products is further divided into refrigerated (-50° Celsius), deep freeze (-80° Celsius), and cryogenic (-196° Celsius). Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment Review
Based on primary packaging containers, the market is segmented into prescription primary containers and OTC primary containers. The prescription primary containers segment is divided into syringe, ampoules, vials, infusion bottles, and others, which include cartridges and blisters. The prescription primary containers segment dominated the global pharmaceutical primary packaging label market in 2020 and is expected to remain dominant throughout the forecast period, owing to factors such as growth in adoption of prescription primary container labels to promote patient understanding and prevent medication misuse, non-adherence, and medication errors.
Based on face material, it is segmented into paper and film. The film segment is further divided into polyethylene, polypropylene, and others, which include COEX plastic packaging, and polyester. The film segment dominated the global pharmaceutical primary packaging label market in 2020 and is anticipated to continue this trend during the forecast period. This is attributed to their durability and moisture resistance and end-to-end sealing properties.
By Primary Packaging Containers
Prescription Primary Containers segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Based on adhesive technology type, it is classified into solvent acrylic, hotmelt rubber, water base emulsion acrylic, and UV curable. The solvent acrylic held the largest market share in 2020 and is expected to remain dominant throughout the forecast period owing to, their high resistance to a number of environmental factors and their suitability to different substrates.
Based on storage type, it is classified into cryogenic & refrigerated storage products and non-refrigerated storage products. The cryogenic & refrigerated storage products held the largest market share in 2020 and is expected to remain dominant throughout the forecast period owing to, increase in products that need to be refrigerated as well as new launches of labels to withstand cryogenic & refrigerated storage products conditions.
By Face Material
Film segment is projected as one of the most lucrative segment.
Snapshot of the Asia-Pacific pharmaceutical primary packaging label Market
Asia-Pacific offers profitable opportunities for key players operating in the pharmaceutical primary packaging label market, thereby registering fastest growth rate during the forecast period, owing to growth in infrastructure of industries, rise in disposable incomes, and well-established presence of domestic companies in the region. In addition, increase in contract-based pharmaceutical packaging and labelling provides a great opportunity for new entrants in this region. In addition, presence of key players such as Lintec Corporation Multi-Color Corporation (MCC) in this region and adoption of new strategies such as acquisition by these key players acts a major factor that contributes toward growth of the pharmaceutical primary packaging label market.
The key market players profiled in the report include Avery Dennison Corporation, CCL Industries, Consolidated Label co., Essentra Plc., Herma GmbH, Lintec Corporation, MCC Label, ProMach, The 3M Company, UPM.
By Region
North America is expected to experience growth at the highest rate, registering a CAGR of 7.10 % during the forecast period.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the global pharmaceutical primary packaging label market along with the current trends and future estimations to explain the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing pharmaceutical primary packaging label market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products of pharmaceutical primary packaging label used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
Pharmaceutical Primary Packaging Label Market Report Highlights
| Aspects | Details |
 By PRIMARY PACKAGING CONTAINERS |
|
 By FACE MATERIAL |
|
 By ADHESIVE TECHNOLOGY TYPE |
|
 By STORAGE TYPE |
|
 By Region |
|
 Key Market Players | THE 3M COMPANY, CONSOLIDATED LABEL CO., UPM, LINTEC CORPORATION, HERMA GmbH, AVERY DENNISON CORPORATION, CCL INDUSTRIES INC., PROMACH, MCC LABEL, ESSENTRA PLC. |
Analyst Review
Pharmaceutical primary packaging labeling refers to process of adding labels to pharmaceutical products to facilitate identification and understanding of important information for end users.
Increase in counterfeiting cases and rise in manufacturing of recyclable and biodegradable label products, rise in adoption of expanded content label design, and increase in demand for cryogenic labels during COVID-19 are some factors, which is expected to propel growth of the pharmaceutical primary packaging label market during the forecast period.
Moreover, growth in use of the smart labelling for patient engagement and identification are expected to offer profitable opportunities for growth of the market during the forecast period. However, stringent government regulations and standards are expected to obstruct the market growth.
The prescription primary containers segment is expected to remain dominant during the forecast period, owing to increase in adoption of prescription primary containers labels to promote patient understanding and prevent medication misuse, non-adherence, and medication errors. Moreover, North America are expected to offer lucrative opportunities to the market during the forecast period, owing to well-established healthcare system demanding proper pharmaceutical primary packaging labelling and stringent rules & regulations related to pharmaceutical primary packaging labelling.
The total market value of pharmaceutical primary packaging label market is $2377.83 million in 2020.
The forcast period for pharmaceutical primary packaging label market is 2021 to 2030
The market value of pharmaceutical primary packaging label market in 2021 is $2556.17 million.
The base year is 2020 in pharmaceutical primary packaging label market
Top companies such as The 3M company, UPM, Avery, CCL Industries, Lintec Corporation, and Essentra Plc. held a high market position in 2020.
The prescription primary containers segment is the most influencing segment owing to increase in adoption of prescription primary containers labels to promote patient understanding and prevent medication misuse, non-adherence, and medication errors.
Increase in counterfeiting cases and rise in manufacturing of recyclable and biodegradable label products, rise in adoption of expanded content label design, and increase in demand for cryogenic labels during COVID-19 are some factors, which is expected to propel growth of the pharmaceutical primary packaging label market during the forecast period.
Asia-Pacific is expected to experience the highest growth rate during the forecast period, owing to growth in infrastructure of industries, rise in disposable incomes, and well-established presence of domestic companies in the region.
The term "pharmaceutical primary packaging label" refers to all the printed information found on the primary packaging of any over-the-counter medicine or prescription drug.
pharmaceutical primary packaging label used to provide instructions and product information to consumers.
Loading Table Of Content...
